Quiz › question 5 of 12 · Long-acting

Which combination of factors raises the risk of virological failure on long-acting cabotegravir + rilpivirine?

A Age over 50 and male sex B Any two of: rilpivirine resistance mutations, subtype A6/A1, BMI ≥ 30 C CD4 nadir below 200 alone D Previous abacavir hypersensitivity